CrossRef Risk factors for atherosclerotic plaque formation in MASLD patients: insights from cross-sectional and Mendelian randomization analyses Wei-hao Peng, Jing Zhang, Yu-hua Ruan, Yan Li, Ye Liu, Ming-jia Dai, Jing-kun Jin, Xue-bin Yan, Fang Ji Nutrition, Metabolism and Cardiovascular Diseases .2026
Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: A randomized double-blind, placebo-controlled trial
The Korean Society of Neurogastroenterology and Motility: 395404
(* A quick note: Wegovy and Ozempic both include semaglutide as their active ingredient
This is really what I consider dangerous. Interest in the trend is being amplified by celebrities